Thermo Fisher Scientific (NYSE:TMO) PT Raised to $640.00

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) had its price target upped by research analysts at The Goldman Sachs Group from $550.00 to $640.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the medical research company’s stock. The Goldman Sachs Group’s […]

Leave a Reply

Your email address will not be published.

Previous post Piper Sandler Raises Bath & Body Works (NYSE:BBWI) Price Target to $45.00
Next post Cantor Fitzgerald Reiterates Overweight Rating for Tenet Healthcare (NYSE:THC)